EGFR and lung carcinoma: Although these studies cannot be directly compared because patients were classified by pathologic stage whereas we used clinical stage, those findings may increase awareness of the need for testing EGFR status, especially because EGFR gene mutations in patients with lung cancer tend to be more common in Asian than in non‐Asian patients.29